Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Geron Corp (NASDAQ:GERN)

1.92
Delayed Data
As of Jan 23
 -0.07 / -3.52%
Today’s Change
1.81
Today|||52-Week Range
3.40
-7.25%
Year-to-Date
3 Beaten-Down Biotech Stocks You Can Buy Right Now
Jan 19 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close1.99
Today’s open1.98
Day’s range1.90 - 2.00
Volume1,469,868
Average volume (3 months)1,571,830
Market cap$316.7M
Dividend yield--
Data as of 4:00pm ET, 01/23/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+3,054.47%
P/E ratioNM
Price/Sales21.65
Price/Book2.22

Competitors

 Today’s
change
Today’s
% change
EDGEEdge Therapeutics In...-0.38-3.45%
ADAPAdaptimmune Therapeu...-0.25-5.54%
AGENAgenus Inc+0.01+0.27%
BOLDAudentes Therapeutic...-0.58-3.78%
Data as of 4:00pm ET, 01/23/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$36.4M
Annual profit (last year)$46.0K
Net profit margin0.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts


Search for Jobs